| Project/Area Number |
09672155
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Chemical pharmacy
|
|---|
| Research Institution | Kyoritsu College of Pharmacy |
|---|
Principal Investigator |
MORISAKI Masuo Kyoritsu College of Pharmacy, Faculty of Pharmaceutical Sciences, Professor (30016159)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
KOBAYASHI Noriko Kyoritsu College of Pharmacy, Faculty of Pharmaceutical Sciences, Research Associate (90245449)
FUJIMOTO Yoshinori Tokyo Institute of Technology, Faculty of Science, Professor (50173472)
森崎 益雄 共立薬科大学, 教授 (30016159)
|
|---|
| Project Period (FY) |
1997 – 1999
|
| Project Status |
Completed (Fiscal Year 1999)
|
| Budget Amount *help |
¥2,300,000 (Direct Cost: ¥2,300,000)
Fiscal Year 1999: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 1998: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 1997: ¥1,300,000 (Direct Cost: ¥1,300,000)
|
|---|
| Keywords | Bile acid / Cholic acid / Cholesterol / Biosynthesis / β-Oxidation / Carbon-carbon bond cleavage reaction / Ethyl ketone / コール酸生合成 / 24-オキソ-THCA / CoAエステル / チオリシス反応 / CoA / β-ケトチオエステル / HepG2 |
|---|
| Research Abstract |
Cholic acid biosynthesis from cholesterol involves C-24/C-25 bond cleavage.
A precursor of this carbon-carbon bond cleavage reaction is 3α, 7α, 12α-trihydroxycoprostan-26-oic acid(THCA) and this acid is thought to be metabolized into cholic acid by a mechanism similar to that of the β-oxidation of fatty acids. Among the intermediates, experimental evidence for the intermediary role of THCA-CoA, 24-ene-THCA-CoA and 24-hydroxy-THCA-CoA has been accumulated. In contrast, little has been known on the formation and metabolism of 24-oxo-THCA-CoA. Our efforts on this line are described here.
The potential substrates including the three THCA-CoA derivatives mentioned above were chemically synthesized, and incubated with rat liver light mitochondria fraction or Hep G2. 24-Oxo-THCA-CoA, if produced during incubation, should be transformed into 27-nor-3α, 7α, 12α-trihydroxy-24-coprostan-24-on ("ethyl ketone") by the subsequent alkaline treatment inducing facile decarboxylation of the intermediate β-keto-carboxylic acid. GC-MS analysis of the trimethylsilyl ether derivatives coming from THCA-CoA, 24-ene-THCA-CoA and 24- hydroxy-THCA CoA clearly detected the "ethyl ketone". These results indicated the enzymic transformation of these three CoA-esters into 24-oxo-THCA-CoA.
Similarly 24-oxo-THCA-CoA was incubated and the subsequent HPLC analysis of the p-bromophenacyl ester derivative indicated the enzymic formation of cholic acid(or cholyl-CoA from 24-oxo-THCA-CoA
Taken together, it is concluded that 24-oxo-THCA-CoA is the final intermediate of cholic acid biosynthesis.
|
